Analyte sensors featuring enhancements for decreasing interferent signal

US12465251B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12465251-B2
Application numberUS-202117347845-A
CountryUS
Kind codeB2
Filing dateJun 15, 2021
Priority dateJul 8, 2020
Publication dateNov 11, 2025
Grant dateNov 11, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise a working electrode comprising an active area disposed thereon and electrode asperities laser planed therefrom. Some analyte sensors may comprise an interferent-reactant species incorporated therewith. Some analyte sensors may comprise an interferent scrubbing electrode. Combinations of these enhancements may additionally be employed.

First claim

Opening claim text (preview).

What is claimed is: 1 . An in-vivo analyte sensor comprising: a working electrode comprising an active area disposed thereon, the active area including an analyte-responsive enzyme; a scrubbing electrode, wherein the scrubbing electrode is positioned in a facing relationship to the active area of the working electrode and the working electrode and scrubbing electrode are separated by a layer between the working electrode and the scrubbing electrode and configured to permit bodily fluids to pass between the working electrode and scrubbing electrode, wherein the scrubbing electrode has a width greater than the working electrode and wherein the scrubbing electrode is configured to reduce a signal attributed to an interferent of the working electrode by pre-reacting the interferent before the interferent reaches the working electrode; and an additional electrode, wherein the additional electrode is at least one of a counter electrode or a reference electrode, wherein the in-vivo analyte sensor is configured for in-vivo use. 2 . The in-vivo analyte sensor of claim 1 , wherein the layer is in the range of 1 μm to 200 μm. 3 . The in-vivo analyte sensor of claim 1 , wherein the width of the scrubbing electrode is from 200 μm to 8000 μm and wherein the working electrode is recessed with respect to the scrubbing electrode. 4 . The in-vivo analyte sensor of claim 1 , wherein the width of the scrubbing electrode to the working electrode is in the range of 2:1 to 50:1. 5 . The in-vivo analyte sensor of claim 1 , wherein the scrubbing electrode has a potential in the range of −2000 mV to +2000 mV. 6 . The in-vivo analyte sensor of claim 1 , wherein the scrubbing electrode is impermeable to an analyte of interest, the analyte of interest being glucose. 7 . The in-vivo analyte sensor of claim 1 , wherein the layer is formed by applying an adhesive, spacer, or other separation means along opposite edges of the working electrode and the scrubbing electrode. 8 . The in-vivo analyte sensor of claim 1 , wherein the layer is sealed along two opposing edges of the scrubbing electrode such that fluid reaches the scrubbing electrode prior to the working electrode. 9 . The in-vivo analyte sensor of claim 1 , wherein the interferent comprises ascorbic acid. 10 . The in-vivo analyte sensor of claim 1 , wherein the scrubbing electrode is coated with an interferent-reactant species. 11 . A method comprising: exposing an in-vivo analyte sensor to a bodily fluid, the analyte sensor comprising: a working electrode comprising an active area disposed thereon, the active area including an analyte-responsive enzyme; a scrubbing electrode, wherein the scrubbing electrode is positioned in a facing relationship to the active area of the working electrode and the working electrode and scrubbing electrode are separated by a layer between the working electrode and scrubbing electrode and configured to permit bodily fluids to pass between the working electrode and scrubbing electrode, wherein the scrubbing electrode has a width greater than the working electrode and wherein the scrubbing electrode is configured to reduce a signal attributed to an interferent of the working electrode by pre-reacting the interferent before the interferent reaches the working electrode; and an additional electrode, wherein the additional electrode is at least one of a counter electrode or a reference electrode. 12 . The method of claim 11 , wherein the layer is in the range of 1 μm to 200 μm. 13 . The method of claim 11 , wherein the scrubbing electrode has a width of 200 μm to 8000 μm. 14 . The method of claim 11 , wherein the width of the scrubbing electrode to the working electrode is in the range of 2:1 to 50:1. 15 . The method of claim 11 , wherein the scrubbing electrode has a potential in the range of −2000 mV to +2000 mV. 16 . The method of claim 11 , wherein the scrubbing electrode is impermeable to an analyte of interest, the analyte of interest being glucose. 17 . The method of claim 11 , wherein the layer is formed by applying an adhesive, spacer, or other separation means along opposite edges of the working electrode and the scrubbing electrode. 18 . The method of claim 11 , wherein the layer is sealed along two opposing edges of the scrubbing electrode such that fluid reaches the scrubbing electrode prior to the working electrode. 19 . The method of claim 11 , wherein the interferent comprises ascorbic acid. 20 . The method of claim 11 , wherein the scrubbing electrode is coated with an interferent-reactant species.

Assignees

Inventors

Classifications

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

  • characterised by the manufacture of electrodes · CPC title

  • invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12465251B2 cover?
Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise a working electrode comprising an active area disposed thereon and electrode asperities laser planed therefrom. Some analyte sensors may comprise an interferent-reactant species i…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).